{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:56:49Z","timestamp":1773277009117,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/cgt.2016.50","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T10:23:50Z","timestamp":1477045430000},"page":"411-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction"],"prefix":"10.1038","volume":"23","author":[{"given":"L A","family":"Rojas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"key":"BFcgt201650_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/156652311796150363","volume":"11","author":"R Khare","year":"2011","unstructured":"Khare R, Chen CY, Weaver EA, Barry MA . Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 2011; 11: 241\u2013258.","journal-title":"Curr Gene Ther"},{"key":"BFcgt201650_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"FR Khuri","year":"2000","unstructured":"Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879\u2013885.","journal-title":"Nat Med"},{"key":"BFcgt201650_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/sj.gt.3301424","volume":"8","author":"J Nemunaitis","year":"2001","unstructured":"Nemunaitis J, Cunningham C, Buchanan A, Blackburn A, Edelman G, Maples P et al. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Therapy 2001; 8: 746\u2013759.","journal-title":"Gene Therapy"},{"key":"BFcgt201650_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ymthe.2006.02.011","volume":"14","author":"EJ Small","year":"2006","unstructured":"Small EJ, Carducci MA, Burke JM, Rodriguez R, Fong L, van Ummersen L et al. A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther 2006; 14: 107\u2013117.","journal-title":"Mol Ther"},{"key":"BFcgt201650_CR5","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1158\/1078-0432.CCR-09-3167","volume":"16","author":"P Nokisalmi","year":"2010","unstructured":"Nokisalmi P, Pesonen S, Escutenaire S, Sarkioja M, Raki M, Cerullo V et al. Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors. Clin Cancer Res 2010; 16: 3035\u20133043.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201650_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/mt.2015.194","volume":"24","author":"J Alonso-Padilla","year":"2016","unstructured":"Alonso-Padilla J, Papp T, Kajan GL, Benko M, Havenga M, Lemckert A et al. Development of Novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs. Mol Ther 2016; 24: 6\u201316.","journal-title":"Mol Ther"},{"key":"BFcgt201650_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","volume":"113","author":"RC Carlisle","year":"2009","unstructured":"Carlisle RC, Di Y, Cerny AM, Sonnen AF, Sim RB, Green NK et al. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood 2009; 113: 1909\u20131918.","journal-title":"Blood"},{"key":"BFcgt201650_CR8","doi-asserted-by":"publisher","first-page":"e1000277","DOI":"10.1371\/journal.ppat.1000277","volume":"5","author":"E Seiradake","year":"2009","unstructured":"Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C et al. The cell adhesion molecule 'CAR' and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog 2009; 5: e1000277.","journal-title":"PLoS Pathog"},{"key":"BFcgt201650_CR9","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/sj.gt.3301961","volume":"10","author":"G Cichon","year":"2003","unstructured":"Cichon G, Boeckh-Herwig S, Kuemin D, Hoffmann C, Schmidt HH, Wehnes E et al. Titer determination of Ad5 in blood: a cautionary note. Gene Therapy 2003; 10: 1012\u20131017.","journal-title":"Gene Therapy"},{"key":"BFcgt201650_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ymthe.2006.01.003","volume":"14","author":"M Lyons","year":"2006","unstructured":"Lyons M, Onion D, Green NK, Aslan K, Rajaratnam R, Bazan-Peregrino M et al. Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. Mol Ther 2006; 14: 118\u2013128.","journal-title":"Mol Ther"},{"key":"BFcgt201650_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1089\/hum.2008.053","volume":"19","author":"M Gimenez-Alejandre","year":"2008","unstructured":"Gimenez-Alejandre M, Cascallo M, Bayo-Puxan N, Alemany R . Coagulation factors determine tumor transduction in vivo. Hum Gene Ther 2008; 19: 1415\u20131419.","journal-title":"Hum Gene Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:10:16Z","timestamp":1647951016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFcgt201650"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2016.50","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"assertion":[{"value":"1 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}